Growing community of inventors

Fauville en Caux, France

Alexandre Le Flohic

Average Co-Inventor Count = 2.11

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Alexandre Le FlohicPhilippe Letellier (2 patents)Alexandre Le FlohicJérôme Guidotti (2 patents)Alexandre Le FlohicLucile Vaysse-Ludot (1 patent)Alexandre Le FlohicMichel Vaultier (1 patent)Alexandre Le FlohicMathieu Pucheault (1 patent)Alexandre Le FlohicThomas Kaminski (1 patent)Alexandre Le FlohicMathieu Grandjean (1 patent)Alexandre Le FlohicJerome Guidotti (0 patent)Alexandre Le FlohicAlexandre Le Flohic (5 patents)Philippe LetellierPhilippe Letellier (10 patents)Jérôme GuidottiJérôme Guidotti (2 patents)Lucile Vaysse-LudotLucile Vaysse-Ludot (9 patents)Michel VaultierMichel Vaultier (6 patents)Mathieu PucheaultMathieu Pucheault (3 patents)Thomas KaminskiThomas Kaminski (1 patent)Mathieu GrandjeanMathieu Grandjean (1 patent)Jerome GuidottiJerome Guidotti (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Les Laboratoires Servier (5 from 290 patents)


5 patents:

1. 10245270 - Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it

2. 9925195 - Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing I

3. 8927708 - Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine

4. 8859763 - Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]OCTA-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

5. 8835627 - Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…